Divis Laboratories Ltd Financials
Company Logo

Divis Laboratories Ltd Financial Statement

Divis Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue2142.00
Operating Expense1442.00
Net Profit430.00
Net Profit Margin20.07
Earning Per Share16.18
EBIDTA705.00
Effective Tax Rate25.43

Divis Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual7,665
Operating Expenses Annual5,491
Operating Profit Annual2,511
Interest Annual3
Depreciation373
Net Profit Annual1,576
Tax Annual556

Divis Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning144
Cash Flow from Operations1,266
Cash Flow from Investing-268
Cash Flow from Financing-798
Cash Flow at the End344

Divis Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)32.77
PBIT Margin (%)27.87
PBT Margin (%)20.90
Net PROFIT Margin (%)20.56
Return On Networth / Equity (%)12.04
Return On Networth /Employed (%)16.27
Return On Assets (%)11.93
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.58

Divis Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual4,737
Total Current Assets Annual9,572
Non Current Assets Annual5,790
Total Shareholders Funds Annual13,484
Total Assets Annual15,362

Divis Laboratories Ltd Earning Calls

EPS (INR)

Expected

16.23

Reported

16.20

Surprise

-0.18%

Mar 2024

EPS beaten by -0.18%

Dec 2023

EPS beaten by -0.25%

Sep 2023

EPS beaten by -0.07%

Get Your FAQs Right

As of Oct 13, 2024, Divis Laboratories Ltd has a market capitalization of 91,234.91 Cr. Value Research classifies it as a Large-Cap company.
Yes, Divis Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Divis Laboratories Ltd recorded a total revenue of approximately 7,665 Cr marking a significant milestone in the company's financial performance.
Divis Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and -0.1% annually, respectively..
Divis Laboratories Ltd's current PE ratio is 57.89.
Divis Laboratories Ltd's ROCE averaged 21.9% from the FY ending March 2022 to 2024, with a median of 18.5%. It peaked at 31.5% in March 2022, reflecting strong capital efficiency over the period..
Divis Laboratories Ltd's latest EBIT is Rs. 2,135 Cr, surpassing the average EBIT of Rs. 2,722.39 Cr over the 5 years..